Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 2—February 2024
Research Letter

Integrating Veterinary Diagnostic Laboratories for Emergency Use Testing during Pandemics1

Natasha F. HodgesComments to Author , McKenzie Sparrer, Tyler Sherman, Treana Mayer, Danielle R. Adney, Izabela Ragan, Molly Carpenter, Christie Mayo2, and Tracy L. Webb2
Author affiliations: Colorado State University, Fort Collins, Colorado, USA (N.F. Hodges, M. Sparrer, T. Sherman, T. Mayer, I. Ragan, M. Carpenter, C. Mayo, T.L. Webb); Lovelace Biomedical, Albuquerque, New Mexico, USA (D.R. Adney)

Main Article

Figure

Population served (A) and perceived funding adequacy (B) of veterinary diagnostic laboratories (VDLs) conducting human SARS-CoV-2 testing, United States. A) Sum of responses for each of 5 selectable testing population types as reported by 13 of 17 VDLs performing human SARS-CoV-2 testing that responded to this optional question. VDLs could select any combination of answers that represented their specific testing populations. LTC, long-term care. B) Percentages of the 11 of 17 VDLs performing human SARS-CoV-2 testing that responded to the optional question to select 1 of 5 funding adequacy descriptions (no responses were received for inadequate).

Figure. Population served (A) and perceived funding adequacy (B) of veterinary diagnostic laboratories (VDLs) conducting human SARS-CoV-2 testing, United States. A) Sum of responses for each of 5 selectable testing population types as reported by 13 of 17 VDLs performing human SARS-CoV-2 testing that responded to this optional question. VDLs could select any combination of answers that represented their specific testing populations. LTC, long-term care. B) Percentages of the 11 of 17 VDLs performing human SARS-CoV-2 testing that responded to the optional question to select 1 of 5 funding adequacy descriptions (no responses were received for inadequate).

Main Article

1Preliminary results from this study were presented at the 65th American Association of Veterinary Laboratory Diagnosticians Conference and the 126th US Animal Health Association Annual Conference, October 6–12, 2022, Minneapolis, Minnesota, USA.

2These authors were co–principal investigators.

Page created: December 04, 2023
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external